Barclays
HALO icon

Barclays’s Halozyme HALO Stock Holding History

Barclays’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,000
Closed -$15K – 7131
2018
Q4 		$15K Hold
1,000
– – ﹤0.01% 6022
2018
Q3 		$18K Hold
1,000
– – ﹤0.01% 6495
2018
Q2 		$17K Sell
1,000
-169,100
-99% -$3.2M ﹤0.01% 6269
2018
Q1 		$3.33M Buy
170,100
+168,600
+11,240% +$3.27M ﹤0.01% 1961
2017
Q4 		$30K Buy
+1,500
New +$27.6K ﹤0.01% 6069
2013
Q3 		– Sell
-248,100
Closed -$1.97M – 7493
2013
Q2 		$1.97M Buy
+248,100
New +$1.58M ﹤0.01% 2553

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Barclays's HALO Position: Q2 2026 in Review

Barclays increased its Halozyme (HALO) stake by 58% in Q2 2026, buying an estimated $7.67M and bringing the position to 305,663 shares worth $23.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Barclays first reported a position in HALO in Q2 2013 and has held it in 53 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Barclays held 305,663 shares of Halozyme worth $23.9M as of Q2 2026.
  • Barclays bought 112,421 Halozyme shares in Q2 2026, an estimated $7.67M.
  • Halozyme made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1037 holding.
  • Barclays first reported a position in Halozyme in Q2 2013 and has held it in 53 quarters since.
  • 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.